Literature DB >> 2583379

Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru.

V R Collins1, G K Dowse, C F Finch, P Z Zimmet, A W Linnane.   

Abstract

Rates of elevated urinary albumin concentration, defined as microalbuminuria (30-299 micrograms/ml) and macroalbuminuria (greater than or equal to 300 micrograms/ml), were determined on random morning urine specimens in the population of Nauru, which has a high prevalence of non-insulin-dependent diabetes mellitus. The prevalence of elevated urinary albumin levels in the total Nauruan population was very high: 26 and 30% of men and women, respectively, had microalbuminuria, whereas 13% of both sexes had macroalbuminuria. Of the subjects with macroalbuminuria, 66% had diabetes. The prevalence increased with worsening glucose tolerance; 26% of subjects with normal glucose tolerance had either micro- or macroalbuminuria, increasing to 43% of subjects with impaired glucose tolerance, 63% of newly diagnosed diabetic subjects, and 75% of previously diagnosed diabetic subjects. Associations between elevated urinary albumin concentration and putative risk factors were assessed for both the total population (n = 1184) and the diabetic subgroup alone (n = 318). Fasting plasma glucose and hypertension were the most important independent correlates for the whole population, whereas plasma creatinine was also important in diabetic subjects. Age at onset and duration of diabetes were not found to be significantly associated with elevated albumin concentration. In subjects with normal glucose tolerance, hypertension and hyperuricemia were the most important associated factors. These results suggest that blood glucose, blood pressure, and possibly obesity and plasma uric acid are important modifiable risk factors for both micro- and macroalbuminuria in this population.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583379     DOI: 10.2337/diab.38.12.1602

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India.

Authors:  A Varghese; R Deepa; M Rema; V Mohan
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

Review 2.  Recent advances in diabetic nephropathy.

Authors:  S M Marshall
Journal:  Postgrad Med J       Date:  2004-11       Impact factor: 2.401

3.  Prevalence and risk factors of albuminuria in Type 2 diabetes in Bahrain.

Authors:  R A Al-Salman; H A Al-Basri; A S Al-Sayyad; H M Hearnshaw
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

4.  Islet cell antibodies and other markers of autoimmunity and diabetes mellitus in Nauruans.

Authors:  S Bakos; I R Mackay; M J Rowley; W Knowles; P Zimmet
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

Review 5.  The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.

Authors:  T Baba; S Neugebauer
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

6.  Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy.

Authors:  R T Erasmus; G Oyeyinka; A Arije
Journal:  Postgrad Med J       Date:  1992-08       Impact factor: 2.401

7.  Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study "Diabetes Care in General Practice", Denmark.

Authors:  N de F Olivarius; A H Andreasen; N Keiding; C E Mogensen
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

8.  Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area.

Authors:  E Standl; H Stiegler
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

9.  Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study.

Authors:  S M Haffner; C Gonzales; R A Valdez; L Mykkänen; H P Hazuda; B D Mitchell; A Monterrosa; M P Stern
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.